Sign in
Groups
Researchers
Results
LINFOMAS Y TRASPLANTES
Tianjin Medical University Cancer Institute and Hospital
Tianjín, China
You are in
Collaborations
Tianjin Medical University Cancer Institute and Hospital
Publications in collaboration with researchers from Tianjin Medical University Cancer Institute and Hospital (1)
2023
ROSEWOOD: A Phase II Randomized Study of Zanubrutinib Plus Obinutuzumab Versus Obinutuzumab Monotherapy in Patients with Relapsed or Refractory Follicular Lymphoma
Journal of Clinical Oncology
Contact
Legal notice
Help
translate
en
arrow_drop_down
translate
en
arrow_drop_down
es
ca
eu
gl
fr
de